Medindia

X

Eisai Inc. and the Alzheimer's Association Announce the Winner of the C.A.R.E. Pharmacy Award

Tuesday, November 25, 2008 General News J E 4
Advertisement
WOODCLIFF LAKE, N.J., Nov. 24 Eisai Inc., in coordinationwith the Alzheimer's Association, announced today the recipient of theC.A.R.E. (Commitment to Alzheimer's. Recognition of Excellence.) PharmacyAward. The C.A.R.E. Pharmacy Award acknowledges a pharmacist who has beennominated by a person with Alzheimer's disease or a caregiver for his or herexceptional impact on the lives of those fighting this disease. The award wasestablished to recognize the critical role that pharmacists play in supportingpeople with Alzheimer's disease and their families.

The C.A.R.E. Pharmacy Award is a reflection of the Eisai human health care(hhc) mission, which regards patients and their families as the most importantparticipants in the health care process. Eisai is proud to be in its eighthyear of recognizing a pharmacist for this accomplishment and is excited tohave been joined by the Alzheimer's Association for the 2008 award.

The recipient of the 2008 C.A.R.E. Pharmacy Award is Tracey Pierce, RPh,CGP, FASCP. Tracey is a clinical pharmacist with Blanchard Valley Hospital inFindlay, Ohio, and a preceptor and associate clinical professor at OhioNorthern University Raabe College of Pharmacy. She donates countless hourseach year conducting family education programs and consultations at healthfairs. As an educator, she encourages her students to also participate inthese programs. As expressed in her nomination, "Tracey is a true patientadvocate."

(Photo: http://www.newscom.com/cgi-bin/prnh/20081124/NYM026 )

"Alzheimer's is a disease that affects both patients and their caregivers.Eisai's commitment to the patient and caregiver communities is unwavering, andcommunity pharmacists play an integral role in each patient's treatment andcare, through ongoing monitoring, counseling and support," said CynthiaSchwalm, President of Eisai Inc. "The C.A.R.E. Pharmacy Award allows us toacknowledge their efforts and showcase best practices in caregivingtechniques. We are proud to be working with the Alzheimer's Association torecognize the outstanding efforts of pharmacists who are making a tangibledifference in the lives of people affected by Alzheimer's disease."

"As a member of the C.A.R.E. Pharmacy Award selection committee, I saw theimpressive contributions of nominated pharmacists who've worked cohesively aspart of a team of care providers for those with Alzheimer's disease," saidPeter Reed, PhD, senior director of programs for the Alzheimer's Association."We commend this year's winner on her extraordinary efforts to build arelationship with those living with Alzheimer's and their caregivers, helpingto educate them about Alzheimer's disease and enhancing the support theyreceive."

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., aresearch-based human health care (hhc) company that discovers, develops andmarkets products throughout the world. Eisai focuses its efforts in threetherapeutic areas: neurology, gastrointestinal disorders and oncology/criticalcare. Established in 1995 and ranked among the top-20 U.S. pharmaceuticalcompanies (based on retail sales), Eisai Inc. began marketing its firstproduct in the United States in 1997 and has rapidly grown to become anintegrated pharmaceutical business with fiscal year 2007 (year ended March 31,2008) sales of approximately $3 billion, including the results of theacquisition of MGI PHARMA, INC.

Eisai Inc. employs approximately 1,900 people at its headquarters inWoodcliff Lake, NJ, at its state-of-the-art pharmaceutical production andformulation research and development facility in Research Triangle Park, NC,and in the field. For more information about Eisai, please visitwww.eisai.com.

About the Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organizationin Alzheimer care, support and research. Our mission is to eliminateAlzheimer's disease through the advancement of research; to provide andenhance care and support for all affected; and to reduce the risk of dementiathrough the promotion of brain health. Our vision is a world withoutAlzheimer's. For more information, visit www.alz.org.

SOURCE Eisai Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Patient Safety Technologies Reports Third Quarter ...
S
Clay Aiken's Bubel/Aiken Foundation Raises Over $5...